NPI | Name | Type | Address |
---|---|---|---|
MRS. RPH Martha J Pineiro |
Individual |
3535 Worth St Ste 500 Dallas, TX |
|
RPH BCOP Megan Ouldhouse |
Individual |
7777 Forest Ln D-220 Dallas, TX |
|
PHARM D Yakeika Sims |
Individual |
3535 Worth Street Dallas, TX |
|
DR. PHARMD Raquel Lashawn Rhone |
Individual |
3535 Worth St Ste 170 Dallas, TX |
|
MR. RPH Billy Bruce Boughton |
Individual |
3535 Worth St Dallas, TX |
|
MS. RPH Phoebe Jane Cook |
Individual |
3535 Worth St Ste 340 Dallas, TX |
|
DR. PHARMD, BCOP Kelli Renee Hill |
Individual |
8220 Walnut Hill Ln Ste 700 Dallas, TX |
|
DR. PHARM.D. Dana Lynne Boyers |
Individual |
3535 Worth St Suite 170 Dallas, TX |
|
MS. R.PH. Margaret Cary Taschek |
Individual |
3535 Worth St Ste 500 Dallas, TX |
|
RPH Janet Newton |
Individual |
1441 N Beckley Ave Dallas, TX |
|
DR. PHARMD Sarah Margaret Gressett |
Individual |
4500 S Lancaster Rd # R119b Dallas, TX |
|
DR. PHARMD Young-sam Won |
Individual |
3535 Worth St Suite 170 Dallas, TX |
|
DR. PHARM.D. Sidney Veach Keisner |
Individual |
4500 S Lancaster Rd Bldg 7, R#119a Dallas, TX |
|
DR. PHARMD, R.PH Jeff D Liticker |
Individual |
2201 Inwood Rd Nc2.852 Dallas, TX |
|
Sonal Reitmeyer |
Individual |
2201 Inwood Rd Nc 2.852 Dallas, TX |
|
DR. PHARM.D. Julian Hoyt Slade III |
Individual |
1441 N Beckley Ave Dallas, TX |
|
DR. PHARM.D. Daniel Clinton Mchugh |
Individual |
4500 S Lancaster Rd Dallas, TX |
|
PHARMD Minh-duong Tran |
Individual |
3410 Worth St Dallas, TX |
|
RPH Katie B Chang |
Individual |
1441 N Beckley Ave Dallas, TX |
|
PHARMD Robert Alan Nunan |
Individual |
7777 Forest Ln Ste C707 Dallas, TX |
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
Taxonomy Code | 1835X0200X |
Specialization | Oncology |
Display Name | Oncology Pharmacist |
Taxonomy Group | Pharmacy Service Providers |
Taxonomy Classification | Pharmacist |
Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
Effective Date | September 30, 2009 |